We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRX icon
4001
Amneal Pharmaceuticals
AMRX
$5.88B
$280K ﹤0.01%
54,262
-9,679
-15% -$55K
ANAB icon
4002
AnaptysBio
ANAB
$1.6B
$277K ﹤0.01%
10,658
-11,238
-51% -$269K
IVOL icon
4003
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$273M
$277K ﹤0.01%
+10,042
New +$286K
STEL
4004
DELISTED
Stellar Bancorp
STEL
$277K ﹤0.01%
10,141
-1,630
-14% -$49.1K
ARDX icon
4005
Ardelyx
ARDX
$1.23B
$276K ﹤0.01%
36,524
-6,939
-16% -$51.3K
DDD icon
4006
CALL
3D Systems Corp
DDD
$611M
$276K ﹤0.01%
+7,200
New +$190K
KGC icon
4007
CALL
Kinross Gold
KGC
$28.2B
$276K ﹤0.01%
43,400
-535,200
-92% -$3.97M
EZJ icon
4008
ProShares Ultra MSCI Japan
EZJ
$13.2M
$275K ﹤0.01%
+5,938
New +$280K
NPTN
4009
DELISTED
NEOPHOTONICS CORP
NPTN
$275K ﹤0.01%
26,986
-4,829
-15% -$51K
LORL
4010
DELISTED
Loral Space and Communications, Inc.
LORL
$274K ﹤0.01%
7,068
-2,301
-25% -$87.4K
BATRA icon
4011
Atlanta Braves Holdings Series A
BATRA
$3.51B
$273K ﹤0.01%
9,671
-3,259
-25% -$90.8K
GES
4012
PUT
DELISTED
Guess Inc
GES
$273K ﹤0.01%
10,700
NRIX icon
4013
Nurix Therapeutics
NRIX
$2.56B
$273K ﹤0.01%
10,313
+487
+5% +$14.3K
BNFT
4014
DELISTED
Benefitfocus, Inc.
BNFT
$273K ﹤0.01%
19,331
-11,854
-38% -$167K
GOGO icon
4015
Gogo Inc
GOGO
$633M
$272K ﹤0.01%
23,820
-15,679
-40% -$181K
AMK
4016
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$272K ﹤0.01%
10,822
-410
-4% -$9.97K
AMTB icon
4017
Amerant Bancorp
AMTB
$1.17B
$271K ﹤0.01%
+12,701
New +$266K
LOCO icon
4018
El Pollo Loco
LOCO
$504M
$271K ﹤0.01%
14,845
-13,644
-48% -$234K
PPLT
4019
abrdn Physical Platinum Shares ETF
PPLT
$2.01B
$271K ﹤0.01%
27,000
+7,000
+35% +$77.4K
NEWP
4020
New Pacific Metals
NEWP
$962M
$270K ﹤0.01%
+55,857
New +$294K
CRNX icon
4021
Crinetics Pharmaceuticals
CRNX
$8.91B
$269K ﹤0.01%
14,290
+3,798
+36% +$66.7K
GOSS icon
4022
Gossamer Bio
GOSS
$87.7M
$268K ﹤0.01%
33,091
-7,233
-18% -$62.7K
SMOG icon
4023
VanEck Low Carbon Energy ETF
SMOG
$133M
$268K ﹤0.01%
+1,666
New +$252K
OIBR.C
4024
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$267K ﹤0.01%
176,580
+20,000
+13% +$30.8K
HCKT icon
4025
Hackett Group
HCKT
$288M
$266K ﹤0.01%
14,811
-9,266
-38% -$161K

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.